Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-19-004419
Filing Date
2019-07-03
Accepted
2019-07-03 17:36:33
Documents
1
Period of Report
2019-07-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3390
  Complete submission text file 0001171843-19-004419.txt   4772
Mailing Address C/O ARIAD PHARMACEUTICALS INC 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
SMITH SANDFORD D (Reporting) CIK: 0001243004 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33672 | Film No.: 19942708

Mailing Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876 301-366-4841
Neuralstem, Inc. (Issuer) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)